Low Dose Aspirin is Associated with Improved 30-and 92-Day Outcomes in Patients with Acute Pancreatitis: A Multinational Multicenter Analysis

Authors

Do Han Kim MD, Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Donghyun Ko MD, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA.Follow
Pedro Palacios Argueta MD, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Wilhelm S. Basegoda MD, University of South Alabama, Mobile, AL, USA
Jose A. Porres, Universidad Francisco Marroquin, Guatemala City, Guatemala.
Frank J. Lukens MD, Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA
Paul T. Kroner MD, Department of Gastroenterology, Riverside Health System, Newport News, VA, USA.

Document Type

Conference Proceeding

Abstract

Currently, no medications are known to formally treat or prevent acute pancreatitis (AP). Significant attention has been devoted to aspirin (ASA), with rodent models showing that it is associated with decreased inflammatory cytokine levels and protects against acinar cell necrosis. Current human studies, which are limited to retrospective inpatient outcomes only on the index hospitalization for AP, do suggest that patients on ASA have improved outcomes. The aim of our study was to explore de 30- and 90- day outcomes of patients with AP on long-term ASA use.

Publication Date

5-2025

Recommended Citation

Kim, Do Han MD; Ko, Donghyun MD; Palacios Argueta, Pedro MD; Basegoda, Wilhelm S. MD; Porres, Jose A.; Lukens, Frank J. MD; and Kroner, Paul T. MD, "Low Dose Aspirin is Associated with Improved 30-and 92-Day Outcomes in Patients with Acute Pancreatitis: A Multinational Multicenter Analysis" (2025). Posters. 96.
https://scholar.bridgeporthospital.org/poster_presentations/96